Characteristics of drugs safety signals that predict safety related product information update-Reference-Cited by-同舟云学术

Characteristics of drugs safety signals that predict safety related product information update

Published:2018-05-24 Issue:7 Volume:27 Page:789-796
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Insani Widya N.¹²^ORCID,Pacurariu Alexandra C.²³^ORCID,Mantel-Teeuwisse Aukje K.¹,Gross-Martirosyan Liana²

Affiliation:

1. Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS); Utrecht University; Utrecht The Netherlands

2. Dutch Medicines Evaluation Board; Utrecht The Netherlands

3. Department of Medical Informatics; Erasmus University Medical Center; Rotterdam The Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference39 articles.

1. Monitoring product safety in the postmarketing environment;Sharrar;Thr Adv Drug Saf,2013

2. The importance of pharmacovigilance for the drug safety: focus on cardiovascular profile of incretin-based therapy;Sportiello;Int J Cardiol,2016

3. Adverse drug reactions monitoring: prospects and impending challenges for pharmacovigilance;Sahu;Springerplus,2014

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse Drug Reactions Related with Antibiotic Medicines in Malawi: A Retrospective Analysis of Prevalence and Associated Factors;Drug, Healthcare and Patient Safety;2024-07

2. An analysis of international strategies for monitoring and preventability described in medicinal product information: a study protocol;2024-06-15

3. The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration;Drug Safety;2024-05-07

4. The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement;Drug Safety;2024-05-07

5. Drug Repurposing Using FDA Adverse Event Reporting System (FAERS) Database;Current Drug Targets;2024-05